Generated: December 16, 2017
DrugPatentWatch Database Preview
Details for Patent: 4,179,507
« Back to Dashboard
Summary for Patent: 4,179,507
|Title:|| Quarternary ammonium compounds|
|Abstract:||Compounds of formula (I): ##STR1## wherein Z.sup.1 and Z.sup.2 are the same or different and each represents a methylenedioxy substituent, or up to three methoxy substituents; R.sup.2 and R.sup.3 are the same or different and each is alkyl having 1-3 carbon atoms, prop-2-enyl or prop-2-ynyl; R.sup.4 and R.sup.5 are the same or different and each is a benzyl or phenethyl group wherein the phenyl ring is optionally substituted by one or more of halogen, alkoxy having 1 to 3 carbon atoms and methylenedioxy; A and B are the same or different and each is an alkylene radical containing 1,2, or 3 carbon atoms; L is an alkylene chain having from 2 to 12 carbon atoms or is a group --L.sup.1.0.L.sup.2 -- wherein each of L.sup.1 and L.sup.2 is alkylene having at least two carbon atoms and taken together L.sup.1 and L.sup.2 having up to 11 carbon atoms; and X.sup.- is an anion; may be used to effect neuromuscular paralysis in mammals.|
|Inventor(s):|| Stenlake; John B. (Glasgow, GB6), Waigh; Roger D. (Wilmslow, GB2), Dewar; George H. (Bath, GB2), Urwin; John (South Shields, GB2), Dhar; Nirmal C. (Glasgow, GB6) |
|Assignee:|| Burroughs Wellcome Co. (Research Triangle Park, NC) |
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Formulation; Use; |
No matches for this query
Foreign Priority and PCT Information for Patent: 4,179,507
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|United Kingdom||50589/75||Dec 10, 1975|
|United Kingdom||45028/76||Oct 29, 1976|
International Patent Family for Patent: 4,179,507
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.